Good morning, ladies and gentlemen and welcome to the Atara Biotherapeutics Q4 and Full Year 2019 Financial Results Conference Call. 99 open jobs for Director manufacturing in Thousand Oaks. Atara plans to further evaluate ATA230 development plans with the FDA and other global health authorities following the initiation of ATA129 EBV-PTLD Phase 3 studies. Atara’s technology platform leverages research collaborations with leading academic institutions with the Company’s scientific, clinical, regulatory and manufacturing expertise. Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Atara Biotherapeutics, Inc. (ATRA) (@Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including solid tumors, hematologic cancers and autoimmune disease. Learn about BIO, register for events and explore member services. For additional information about the company, please visit atarabio.com and follow us on Twitter and LinkedIn. Bayer and Atara Biotherapeutics, Inc. ... Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is … Atara Biotherapeutics Inc. is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. The cell therapy facility, which could open in 2023, offers more insight into Bayer's plans and how it could compete with emerging bio-manufacturing companies such as Resilience. Verified employers. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility. Atara Biotherapeutics Announces First Quarter 2018 Financial Results and Recent Operational Progress . Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Our mission - "Transform the lives of patients with serious medical conditions through pioneering science, teamwork, and a commitment to excellence." Free, fast and easy way find a job of 901.000+ postings in Thousand Oaks, CA and other big cities in USA. Competitive salary. Our mission - "Transform the lives of patients with serious medical conditions through pioneering science, teamwork, and a commitment to excellence." Scientist - Upstream Viral Vector Process Development, with an estimated salary of $200,000 - $250,000. Search and apply for the latest Senior art director jobs in Thousand Oaks, CA. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease, today named cell therapy and oncology expert Cokey Nguyen, Ph.D. as Chief Scientific Officer. Our mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork, and a commitment to excellence.” Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease, today reported the grant of inducement awards to Cokey Nguyen, its Senior Vice President, Chief Scientific Officer. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California. Full-time, temporary, and part-time jobs. Facility commissioning and qualification activities to support clinical development at our Operations and Manufacturing facility, ATOM, are … Atara Biotherapeutics opened a $55 million manufacturing facility in June of 2018 in Thousand Oaks, Calif. Role model for Atara TRAIT values (Transparency, Respect, Accountability, Integrity, Trust). Atara Biotherapeutics, Inc. is hiring a Scientist/ Sr. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for … Our Southern California hub is anchored by a new 90,000 sq. Cell Therapy Manufacturing: Installed Global Capacity (Cleanroom Area) 13.3. Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Atara Biotherapeutics | 17 227 abonnés sur LinkedIn. Bayer and Atara Biotherapeutics, Inc. (Nasdaq: ATRA) today announced an exclusive worldwide license agreement and research, development and manufacturing collaboration for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors. Job email alerts. Our mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork, and a commitment to excellence.” Atara Biotherapeutics, Inc. (@Atarabio) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. The company was founded in 2012 and is co-located in South San Francisco and Southern California. Leases First of Nine Buildings Underway in Conejo Spectrum by SRG Commercial ... cellular therapy manufacturing facility … Verified employers. Atara Biotherapeutics Inc., a clinical-stage biopharmaceutical company headquartered in South San Francisco, will move its research and development division to Thousand Oaks by the end of the year, according to the Conejo Valley city. Thursday July 9th. Competitive salary. Search and apply for the latest Regulatory operations specialist jobs in Thousand Oaks, CA. SOUTH SAN FRANCISCO, Calif., May 8, 2018 (GLOBE NEWSWIRE) --Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today reported … The Onco Cell Therapy Summit (OCTS), November 16 - 18, Boston USA, brings the industry together to share novel research, manufacturing techniques, and regulatory best practice. Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. About Atara Biotherapeutics, Inc. ... Our Southern California hub is anchored by the state-of-the-art Atara T-cell Operations and Manufacturing (ATOM) facility in … ... state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility. AMSTERDAM and SAN FRANCISCO, CA – 26 October 2020 –. For additional information about the company, please visit atarabio.com. Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. About Atara Biotherapeutics, Inc. ... Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is … Our Southern California hub is anchored by a new 90,000 sq. Designed by HPA Architects to meet LEED sustainable design criteria, the Atara T-cell Operations and Manufacturing (ATOM) center houses a 90,000-sf facility for the production of CAR-T allogeneic therapies, as well as additional R&D labs and offices. Atara Biotherapeutics to Announce First Quarter 2021 Financial Results on Tuesday, May 4, 2021. Atara Biotherapeutics Opens State-of-the-Art Operations and Manufacturing Facility to Support Robust Off-the-Shelf T-Cell Immunotherapy Pipeline … For additional information about the company, please visit atarabio.com. Atara’s technology platform leverages research collaborations with leading academic institutions with the Company’s scientific, clinical, regulatory, and Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease, today announced that Company management will participate at two upcoming virtual conferences. Competitive salary. About Atara Biotherapeutics, Inc. ... Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is … 13.2.1.3. Atara Biotherapeutics has initiated construction of a new CAR-T gene therapy manufacturing facility in Thousand Oaks, California, where it will produce cells for allogeneic treatments. Atara Biotherapeutics | 19.200 Follower auf LinkedIn Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. Atara Biotherapeutics USA Listed Atara Biotherapeutics, Inc. is a privately-held drug development company with a focus on innovative therapies for patients with debilitating diseases. Wednesday July 8th. About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. (@Atarabio) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for … This "CAR T-cell Therapy - Pipeline Insight, 2021," report provides comprehensive insights about 300+ companies and 300+ pipeline drugs … Verified employers. The Company was founded in 2012 and is co-located in South San Francisco and Southern California. Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. ... JCET Innovation and Manufacturing St.. [General]Cable One … Atara Biotherapeutics has opened its Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, CA. The agreement includes the development candidate ATA3271, an armored allogeneic T-cell immunotherapy, and an autologous … Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for … Atara Biotherapeutics (Nasdaq: ATRA) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Our Southern California hub is anchored by a new 90,000 sq. Commercial-Scale Biotherapeutics Manufacturing Facility for Plant-Made Pharmaceuticals. Atara Biotherapeutics | 19 105 sledujících uživatelů na LinkedIn. Our Southern California hub is anchored by a new 90,000 sq. Live Conference Call and Webcast at 4:30 p.m. EDT. Atara Biotherapeutics, Inc. is a leading cell therapy company developing novel treatments for patients with cancer and autoimmune diseases. Berlin, Germany/South San Francisco, California, US, December 7, 2020 – Bayer AG and Atara Biotherapeutics today announced an exclusive worldwide license agreement for next-generation, mesothelin-directed CAR-T cell therapies for the treatment of solid tumors.The agreement includes the development candidate ATA3271, an armored next generation allogeneic T-cell immunotherapy, and … Atara Biotherapeutics, Inc. ... Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Contact: Media Kerry Beth Daly Head, Corporate Communications Atara Biotherapeutics Bayer and Atara Biotherapeutics, Inc. (Nasdaq: ATRA) today announced an exclusive worldwide license agreement and research, development and manufacturing collaboration for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors. Prockop S et al. 62 Atara Manufacturing Senior jobs available in California on Indeed.com. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility. Atara Biotherapeutics is a leading T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Berlin, Germany/South San Francisco, California, US, December 7, 2020 – Bayer AG and Atara Biotherapeutics today announced an exclusive worldwide license agreement for next-generation, mesothelin-directed CAR-T cell therapies for the treatment of solid tumors.The agreement includes the development candidate ATA3271, an armored next generation allogeneic T-cell immunotherapy, and … ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility. ET. Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. ATOM features approximately 90,000 square feet dedicated to manufacturing the company's off-the-shelf T-cell immunotherapies, as well as additional space for R&D labs and offices for Atara's Southern California technical operations. ATOM features approximately 90,000 square feet dedicated to manufacturing the company's off-the-shelf T-cell immunotherapies, as well as additional space for R&D labs and offices for Atara's Southern California technical operations. Atara Biotherapeutics ... proceeds from the December 2020 financing and proceeds from stocks sold through our ATM facility. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility. Atara Biotherapeutics opened a $55 million manufacturing facility in June of 2018 in Thousand Oaks, Calif. Apply to Senior Research Scientist, Director of Quality Assurance, Project Coordinator and more! Atara plans to further evaluate ATA230 development plans with the FDA and other global health authorities following the initiation of ATA129 EBV-PTLD Phase 3 studies. About Atara Biotherapeutics, Inc. ... Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is … At nearly 91,000 square feet, the facility will be the main hub for manufacturing the company’s T-cells, which are designed to destroy cancers associated with the Epstein-Barr virus. About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. ... Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Our Southern California hub is anchored by a new 90,000 sq. Our mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork, and a commitment to excellence.” Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced an updated development plan for the Phase 3 tab-cel® (tabelecleucel) program for patients with Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD). We continue to innovate at our manufacturing facility in Southern California. For additional information about the company, please visit atarabio.com and follow us on Twitter and LinkedIn. Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. For additional information about the company, please visit atarabio.com and follow us on Twitter and LinkedIn. April 20, 2017 By Alex Keown, BioSpace.com Breaking News Staff THOUSAND OAKS, Calif. – Atara Biotherapeutics secured a 90,000-square-foot building to expand the company’s cellular therapy manufacturing facilities. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q1 2021 Earnings Conference Call May 4, 2021 4:30 PM ET Company Participants. Free, fast and easy way find a job of 715.000+ postings in Thousand Oaks, CA and other big cities in USA. Our Southern California hub is anchored by a new 90,000 sq. Job email alerts. Full-time, temporary, and part-time jobs. Atara Biotherapeutics opened a $55 million manufacturing facility in June of 2018 in Thousand Oaks, Calif. Atara Biotherapeutics | LinkedIn‘de 19.028 takipçi Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. ... stability issues, consistency and timely availability of reagents or raw materials. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including solid tumors, hematologic cancers and autoimmune disease, today reported financial results for the second quarter ended June 30, 2020 and recent business highlights. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced the Company will release first quarter 2021 financial results after market close on … ... Atara Biotherapeutics … ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility. Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. Atara Biotherapeutics Inc (ATRA) Q4 2020 Earnings Call Transcript. For additional information about the company, please visit atarabio.com and follow us … Atara Biotherapeutics, Inc. ... Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Atara Biotherapeutics to Announce First Quarter 2021 Financial Results on Tuesday, May 4, 2021. Our Southern California hub is anchored by the state-of-the-art Atara T-cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California. ... development and manufacturing facility is based in Thousand Oaks, California. Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Atara Biotherapeutics, Inc. is a leading cell therapy company developing novel treatments for patients with cancer and autoimmune diseases. Improving patients' lives is our mission and we will never stop working to bring transformative therapies to those in need. The Viral Vector Upstream Process Development Scientist/Sr. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced the Company will release first quarter 2021 … The Biotechnology Innovation Organization is the world's largest biotech trade association. The company was founded in 2012 and is co-located in South San Francisco and Southern California. Atara Biotherapeutics | 18.572 volgers op LinkedIn. Introduction In recent years, the plant‐made pharmaceutical (PMP) community has made significant progress in bringing therapeutics to the clinic: Elelyso™ (Pastores et al., 2014; Zimran et al., 2015) (Protalix, Carmiel, Israel) has been given market …. Tweet. Atara Biotherapeutics | 18,579 pengikut di LinkedIn. Our Southern California hub is anchored by a new 90,000 sq. Atara has a dedicated, expandable manufacturing facility with the flexibility to produce multiple T-cell and CAR T immunotherapies. Actor ran … Atara Biotherapeutics, Inc. Full-time, temporary, and part-time jobs. Analysis by Location of Manufacturing Facility 13.2.2. ASH 2019; Prockop S et al. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced the Company will release first quarter 2021 financial results after market close on … Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Atara Biotherapeutics | 19.200 Follower auf LinkedIn Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. Bayer and Atara Biotherapeutics, Inc. (Nasdaq: ATRA) today announced an exclusive worldwide license agreement and research, development and manufacturing collaboration for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors. Atara leased the space for 15 years from Irvine, Calif.-based SARES•REGIS Group (SRG).The facility is part of SRG’s 507,878-square-foot development. Forward-Looking Statements Designed by HPA Architects to meet LEED sustainable design criteria, the Atara T-cell Operations and Manufacturing (ATOM) center houses a 90,000-sf facility for the production of CAR-T allogeneic therapies, as well as additional R&D labs and offices. Atara Biotherapeutics, Inc. 10-Q for ATARA BIOTHERAPEUTICS, INC. - Sample agreements, legal documents, and contracts from RealDealDocs. Atara Biotherapeutics | 在领英上有 18,092 位关注者。Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. Tuesday July 7th. Atara Biotherapeutics, Inc. ( @Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, … The "CAR T - Cell Therapy - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. About Atara Biotherapeutics, Inc. ... Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is … Atara Biotherapeutics Announces First Quarter 2021 Financial Results and Operational Progress. Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. Agenda: 2020 Onco Cell Therapy Summit. Search Director manufacturing jobs in Thousand Oaks, CA with company ratings & salaries. Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Atara Biotherapeutics USA Listed Atara Biotherapeutics, Inc. is a privately-held drug development company with a focus on innovative therapies for patients with debilitating diseases. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced the appointment of immunology and cell & gene therapy expert Maria Grazia Roncarolo, MD, to the Board … Email or phone. Search and apply for the latest Mission support specialist jobs in Thousand Oaks, CA. This role is responsible for planning, performing, analyzing, summarizing, reporting, and presenting experimental results related to Upstream Process development, optimization, tech transfer and troubleshooting. Each session of OCTS 2021 is dedicated to the process of translating R&D into commercially viable oncological therapies. Scientist is a part of a growing viral vector process development team supporting Atara’s T-cell therapy programs. Free, fast and easy way find a job of 616.000+ postings in Thousand Oaks, CA and other big cities in USA. Our Southern California hub is anchored by the state-of-the-art Atara T-cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California. At this … With this cash balance and projected revenue from U.S. tab … About Atara Biotherapeutics, Inc. ... Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is … Eric Hyllengren - Vice President of Investor Relations and Finance. Atara Biotherapeutics, Inc. (@Atarabio) is an off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. Atara Biotherapeutics has opened its Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, CA. Sign in to save Director, Quality Compliance at Atara Biotherapeutics. Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. Atara Biotherapeutics Inc., a clinical-stage biopharmaceutical company headquartered in South San Francisco, will move its research and development division to Thousand Oaks by the end of the year, according to the Conejo Valley city. Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. Our Southern California hub is anchored by the state-of-the-art Atara T-cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California. Atara Biotherapeutics | 17,619 followers on LinkedIn. About Atara Biotherapeutics, Inc. ... Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is …
Emdr Therapy Retreats,
Converted Warehouse Apartments Philadelphia,
Allman Park Apartments - Medford, Wi,
Electronic Crimes Task Force,
Pitt Meadows Golf Club Membership,
Heavyweight Champagne Stopper,
Brampton Huronia Brick,
Tax And Accounting Services Near Me,
Ccsd 2021-22 Calendar,
Sherwin Williams Memorial Day Sale,
Waterline Square Rental Floor Plans,